← The Lantern · New Carlisle
health · class iii

AuroMedics Pharma LLC recalls Glycopyrrolate Injection, USP 4 mg per 20 mL (0.2 mg/mL)…

The stated reason: Failed Impurities/Degradation Specifications: elevated levels of Benzaldehyde impurity was found in investigative samples (retain samples).

Illustration: a small clinic exam room with an exam table, a stethoscope and a clipboard
Illustration · The Lantern

AuroMedics Pharma LLC began a drug recall on February 07, 2020 whose reported distribution included Ohio. FDA

What the record shows

FDA graded it Class III — use is not likely to cause adverse health consequences. Quantity affected: 4600 Vials. The recall is listed as terminated. FDA

1 source

Context

This is one of 1 records of this type (Class Iii) from this source in the year preceding it. FDA

The Lantern holds 60 records from this source in total, and 2880 for New Carlisle across every source. FDA

1 source

By the numbers

  • Date of record: February 07, 2020 FDA
  • Recall number: D-0853-2020 FDA
  • Recalls in this action: 1 FDA
  • Recalling firm: AuroMedics Pharma LLC FDA
  • Product: Glycopyrrolate Injection, USP 4 mg per 20 mL (0.2 mg/mL), 20 mL Multiple Dose Vial, Rx Only, For Intramuscular or… FDA
  • Reason for recall: Failed Impurities/Degradation Specifications: elevated levels of Benzaldehyde impurity was found in investigative… FDA
1 source
How we know this:

Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA

Sources

The source filing

Recall numberD-0853-2020
Recalls in this action1
Recalling firmAuroMedics Pharma LLC
ProductGlycopyrrolate Injection, USP 4 mg per 20 mL (0.2 mg/mL), 20 mL Multiple Dose Vial, Rx Only, For Intramuscular or Intravenous Use, Not for Use in Newborns, Contains Benzyl Alcohol, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ, 08520, Made in India, NDC 55150-295-20.
Reason for recallFailed Impurities/Degradation Specifications: elevated levels of Benzaldehyde impurity was found in investigative samples (retain samples).
ClassificationClass III — use is not likely to cause adverse health consequences
Recall typedrug
Quantity4600 Vials
StatusTerminated
Voluntary or mandatedVoluntary: Firm initiated
Initiated20200207
Reported20200226
DistributionOhio, Louisiana, Mississippi
Firm locationEast Windsor, NJ, United States
View the original at fda.gov

Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.

More from Clark County, OHWatch records like this
“Oh, No!” Have we made an error? Report it to us here! We are eager to correct the record.